Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Opolon

Showing results (241-250 of 252) with videos related to

Pageof 26
Sort By:
Hepatology (Baltimore, Md.)|May 29, 1999
Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatmentD C Valla, M Chevallier, P Marcellin, et al.
British Journal of Cancer|August 5, 2004
No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecanL Calvet, A Santos, A Valent, et al.
Human Gene Therapy|September 30, 2006
Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancerJ-Y Pillé, H Li, E Blot, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2005
Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivoJ-Y Pillé, C Denoyelle, J Varet, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
Three cases of severe subfulminant hepatitis in heart-transplanted patients after nosocomial transmission of a mutant hepatitis B virusL Stuyver, S De Gendt, J F Cadranel, et al.
Journal of Virology|June 1, 1997
Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenovirusesJ F Dedieu, E Vigne, C Torrent, et al.
Cell Death & Disease|September 19, 2014
Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancerY Loriot, P Mordant, D Dugue, et al.
Journal of the National Cancer Institute|December 18, 1996
Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patientsT Tursz, A L Cesne, P Baldeyrou, et al.
Gastroenterology|October 21, 2000
Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survivalF Lunel, J F Cadranel, M Rosenheim, et al.
The Journal of Clinical Investigation|December 31, 1997
Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral productsH Gahéry-Ségard, V Molinier-Frenkel, C Le Boulaire, et al.
Pageof 26

Showing results (241-250 of 252) with videos related to

Sort By:
Pageof 26
Hepatology (Baltimore, Md.)|May 29, 1999
Treatment of hepatitis C virus-related cirrhosis: a randomized, controlled trial of interferon alfa-2b versus no treatmentD C Valla, M Chevallier, P Marcellin, et al.
British Journal of Cancer|August 5, 2004
No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecanL Calvet, A Santos, A Valent, et al.
Human Gene Therapy|September 30, 2006
Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancerJ-Y Pillé, H Li, E Blot, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 26, 2005
Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivoJ-Y Pillé, C Denoyelle, J Varet, et al.
Hepatology (Baltimore, Md.)|May 29, 1999
Three cases of severe subfulminant hepatitis in heart-transplanted patients after nosocomial transmission of a mutant hepatitis B virusL Stuyver, S De Gendt, J F Cadranel, et al.
Journal of Virology|June 1, 1997
Long-term gene delivery into the livers of immunocompetent mice with E1/E4-defective adenovirusesJ F Dedieu, E Vigne, C Torrent, et al.
Cell Death & Disease|September 19, 2014
Radiosensitization by a novel Bcl-2 and Bcl-XL inhibitor S44563 in small-cell lung cancerY Loriot, P Mordant, D Dugue, et al.
Journal of the National Cancer Institute|December 18, 1996
Phase I study of a recombinant adenovirus-mediated gene transfer in lung cancer patientsT Tursz, A L Cesne, P Baldeyrou, et al.
Gastroenterology|October 21, 2000
Hepatitis virus infections in heart transplant recipients: epidemiology, natural history, characteristics, and impact on survivalF Lunel, J F Cadranel, M Rosenheim, et al.
The Journal of Clinical Investigation|December 31, 1997
Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral productsH Gahéry-Ségard, V Molinier-Frenkel, C Le Boulaire, et al.
Pageof 26